{
  "trial_id": "NCT02777827",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Provision of informed consent before any study specific procedures",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Men or non-pregnant, non-lactating women 18 to 75 years of age, inclusive",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Non-smoker or ex-smoker (quit \u22656months prior to Visit 1) with a total smoking history of \u226410 pack years",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Documented clinical diagnosis of asthma for \u22656 months before Visit 1 according to GINA guidelines",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "On stable dose of ICS or ICS/LABA FDC, for at least 1 month prior to Visit 1, at the doses approved in the country of enrolment",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Prebronchodilator FEV1 at Visit 2 \u226540% and \u226485% of predicted (1 repetition of the test is allowed before screen failure)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Reversibility to salbutamol (per American Thoracic Society (ATS)/European Respiratory Society (ERS) criteria, 2005 ie, \u226512% and \u2265200 mL) at Visit 2 (1 repetition of the test is allowed before screen failure)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Demonstrate the ability to use the study inhalation device properly",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Able to perform repeated pulmonary function testing for FEV1",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Able to read, speak and understand German",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient must agree to all restrictions during the study",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Participation in another clinical study with an IP during the last 3 months",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known or suspected hypersensitivity to the IP or excipients, including lactose (Note: Systemic steroid use in the 6 weeks before Visit 1)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Hospitalization due to asthma in the 6 months prior to Visit 1",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 15-year-old boy with asthma diagnosed a year ago. He presents with shortness of breath, chest tightening and cough.",
  "_meta": {
    "topic_id": "59",
    "trial_id": "NCT02777827",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}